$3250 | Single User
$4650 | Site License
$5650 | Global License

Biosimilars Market, By Product Type (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Recombinant Peptides), Application (Oncology, Blood Disorders, Infectious Diseases, Autoimmune Diseases, Other Diseases) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated
[Lowest Price Guaranteed: $3,250]

Published by AnalystView: 01 Jul 2020 | 270596 | In Stock
Related Topics: AstraZeneca , Biosimilars , Blood , COVID , Infectious Disease , Novartis , Pfizer , Pharmaceuticals , Protein

Introduction

REPORT HIGHLIGHT

The “Global Biosimilars Market- – Industry Analysis, Share, Trend, Market Size and Forecast” was estimated to be around US$ 11.69 billion in 2019 and is anticipated to grow with 26.9% of growth rate during the future period.

This report segments the global Biosimilars Market by product type, application and geography. Biosimilars are the biologics pharmaceutical drugs which are similar to the reference biologic products. These drugs are an interchangeable biological product that contains synthetically developed protein molecules. When the patent of branded drug is expired, pharmaceutical companies are planning to develop off-patent biologics i.e. biosimilars that offer similar biological activity. The biosimilars market offers many growth opportunities and driving factors as compared to the restraining factors. It is stated by various research scientists that development of biosimilars will drastically reduce the price of pharmaceutical drugs.

COVID-19's Multifaceted Impact on Biosimilars Industry

As the COVID-19 pandemic spreads, this will continue to affect the global biopharmaceutical industry. Biosimilars are no exception, and the impact on its demand and adoption will be multifaceted. The propose report discuss three possible forecast scenarios (probable, optimistic, and pessimistic) considering the COVID-19 impact. Our ongoing research analysis amplifies our framework to ensure the inclusion of underlying COVID-19 crisis impact and potential paths forward. The designed report is delivering detailed insights on COVID-19 considering the changes in consumer demand, purchasing patterns, re-routing of the supply chain, and the significant interventions of governments. The updated study provides insights, and forecast, considering the COVID-19 impact on the market.

In terms of product types, the market for recombinant glycosylated proteins continue to dominate during the forecast period, while the market for recombinant non-glycosylated proteins biosimilars will see a huge potential during the forecast period. On other side, oncology was the largest application segment in 2016, and expected to be the fastest growing application segment in the forecast period.

Companies reported in this report are: Amgen, Inc, AstraZeneca, Pfizer, Inc., BIOCON Limited, Novartis AG, STADA, Teva Pharmaceuticals Inc. and Others. For company profiles in the report, 2014 has been considered. Where information is unavailable for the base year, the prior year has been considered.

The market size and forecast for each segment has been provided for the period 2016 to 2027, considering 2019 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2021 to 2027 for every reported segment.

The years considered for the study are:

Historical Year – 2016 to 2018

Base Year – 2019

Estimated Year – 2020

Projected Year – 2027

The proposed reports analyse and evaluates the COVID-19 impact, and anticipated change on the future market scenario on this industry, by taking into the account the economic, political, technological, and social, parameters.

The research report categorizes the Biosimilars Market in each of the following submarkets to forecast the revenues and analyze the trends:

GLOBAL BIOSIMILARS MARKET, BY PRODUCT TYPES

Recombinant Glycosylated Proteins

Recombinant Non-Glycosylated Proteins

Recombinant Peptides

GLOBAL BIOSIMILARS MARKET, BY APPLICATION

Oncology

Blood Disorders

Infectious Diseases

Autoimmune Diseases

Others

GLOBAL BIOSIMILARS MARKET, BY REGION

North America

Europe

Asia Pacific

Rest of the World

Table of Contents
for Biosimilars Market, By Product Type (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Recombinant Peptides), Application (Oncology, Blood Disorders, Infectious Diseases, Autoimmune Diseases, Other Diseases) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated

  • TABLE OF CONTENT

    BIOSIMILARS MARKET OVERVIEW

    Study Scope

    Base Year

    Assumption and Methodology

    EXECUTIVE SUMMARY

    Key Market Facts

    Geographical Scenario

    Companies in the Market

    BIOSIMILARS MARKETKEY MARKET TRENDS

    Market Drivers

    Impact Analysis of Market Drivers

    Market Restraints

    Impact Analysis of Market Restraints

    Market Opportunities

    Market Future Trends

    BIOSIMILARS MARKETINDUSTRY STUDY

    Pipeline Therapeutic Analysis

    Pricing Analysis

    New Introduction by Leading Companies

    BIOSIMILARS MARKET LANDSCAPE

    Market Share Analysis

    Key Innovators

    BIOSIMILARS MARKET – BY PRODUCT TYPES:

    Overview

    Recombinant Glycosylated Proteins

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Recombinant Non-Glycosylated Proteins

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Recombinant Peptides

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    BIOSIMILARS MARKET – BY APPLICATION:

    Overview

    Oncology

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Blood Disorders

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Infectious Diseases

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Autoimmune Diseases

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Other Diseases

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    BIOSIMILARS MARKET– BY GEOGRAPHY

    Introduction

    North America

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    U.S.

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Canada

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Europe

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    France

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Germany

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Rest of Europe

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Asia Pacific (APAC)

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    China

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    India

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Rest of APAC

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Rest of the World

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Latin America

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Middle East and Africa

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    KEY VENDOR ANALYSIS

    Astra Zeneca, plc

    Company Overview

    SWOT Analysis

    Key Developments

    Amgen, Inc.

    Company Overview

    SWOT Analysis

    Key Developments

    Pfizer, Inc.

    Company Overview

    SWOT Analysis

    Key Developments

    Biocon Ltd.

    Company Overview

    SWOT Analysis

    Key Developments

    Novartis AG

    Company Overview

    SWOT Analysis

    Key Developments

    Teva Pharma

    Company Overview

    SWOT Analysis

    Key Developments

    STADA AG

    Company Overview

    SWOT Analysis

    Key Developments

    360 DEGREE ANALYSTVIEW

    APPENDIX

    Research Methodology

    Abbreviations

    Disclaimer

    Contact Us

    SCOPE AND OBJECTIVES

    The objective of this report is to describe the market trends and revenue forecasts for the Biosimilars Market for the upcoming years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

    The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the coil coatings market. The scope of this report covers the Biosimilars Market by its major segments, which include the type, end user industry, and the major geographic regions.

    KEY BENEFITS OF THE REPORT:

    Understanding of the strategies that are being adopted by the key players in this market to stay competitive

    Extensive analysis of the key players dominating the competitive landscape of this market

    In-depth analysis of the key factors are propelling the growth of the global market

    Detailed analysis of the geographic region that will witness the strongest growth

    Granular analysis of the current market scenario and the expected market grow

    KEY PREMIUM INSIGHTS:

    Rising consumer wealth and income levels, increasing government and patient awareness, and a trend towards healthier lifestyles are anticipated to boost health care spending to around 8.1% in 2014-2018 in Asia Pacific

    Biosimilars require high costs of investment and require a time frame to 7-8 years to enter the market

    Economic expansion and government focus on broader welfare policies will drive the market for biosimilars.

List Of Tables
in Biosimilars Market, By Product Type (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Recombinant Peptides), Application (Oncology, Blood Disorders, Infectious Diseases, Autoimmune Diseases, Other Diseases) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated

List of Tables

Table 1 List of Acronyms

Table 2 Key Market Facts, 2014 - 2025

Table 3 Market Drivers: Impact Analysis

Table 4 Market Restraint: Impact Analysis

Table 5 Market Opportunity: Impact Analysis

Table 6 PESTLE Analysis

Table 7 Porter's Five Forces Analysis

Table 8 Company Market Share Analysis

Table 9 Global Biosimilars Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

Figure 10 Biosimilars Market, by Product Type, 2016 – 2027 (USD Million)

Figure 11 Biosimilars Market, by Application, 2016 – 2027 (USD Million)

Figure 12 Biosimilars Market, by Geography, 2016 – 2027 (USD Million)

Table 13 North America Biosimilars Market, 2016 – 2027 (USD Million)

Table 14 U.S. Biosimilars Market, 2016 – 2027 (USD Million)

Table 15 Canada Biosimilars Market, 2016 – 2027 (USD Million)

Table 16 Europe Biosimilars Market, 2016 – 2027 (USD Million)

Table 17 France Biosimilars Market, 2016 – 2027 (USD Million)

Table 18 Germany Biosimilars Market, 2016 – 2027 (USD Million)

Table 19 Asia Pacific Biosimilars Market, 2016 – 2027 (USD Million)

Table 20 China Biosimilars Market, 2016 – 2027 (USD Million)

Table 21 India Biosimilars Market, 2016 – 2027 (USD Million)

Table 22 Latin America Biosimilars Market, 2016 – 2027 (USD Million)

Table 23 MEA Biosimilars Market, 2016 – 2027 (USD Million)

List Of Figures, Charts and Diagrams
in Biosimilars Market, By Product Type (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Recombinant Peptides), Application (Oncology, Blood Disorders, Infectious Diseases, Autoimmune Diseases, Other Diseases) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated

List of Figures

Figure 1 Research Methdology

Figure 2 Research Process Flow Chart

Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)

Figure 4 Regulatory Framework Analysis

Figure 5 Value Chain Analysis Analysis

Figure 6 Biosimilars Market, by Product Type, 2016 – 2027 (USD Million)

Figure 7 Biosimilars Market, by Application, 2016 – 2027 (USD Million)

Figure 8 Biosimilars Market, by Geography, 2016 – 2027 (USD Million)

Additional Details

Publisher

AnalystView

Publisher Information

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.



These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.



We aim to be the number one choice for various clients who require credible data to make vital business decisions. We wish to be a trusted and reliable analytics partner to major business organizations.



We understand that critical business decisions can be taken only when verified, authentic information is available. Therefore, our experts work meticulously to provide our clients with the accurate data, so that they need not spend time in verifying it.



It is also our goal to help our clients ignore traditional research methods that require a large amount of capital, manpower, and most important of it all – the time. We know that these factors are precious to a company and always follow the latest research techniques that produce the required result in a short span of time.

Reference

270596 | AV134

Number of Pages

230

Report Format

PDF

AnalystView Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Biosimilars in Oncology: Update Bulletin [Feb 2016]
Introduction new KOL insights on the latest events that have the potential to shape the oncology bio...
01 Feb 2016 by FirstWord Pharma USD $995 More Info
Biosimilars in Oncology: KOL Insight
IntroductionWill physicians ever adopt Biosimilars in Oncology?Sceptical, survival focussed oncologi...
01 Jan 2016 by FirstWord Pharma USD $7,900 More Info
Biosimilars: European Payer Perspectives (2016)
IntroductionWhat’s driving the uptake of biosimilars in Europe and what still needs to be done?The E...
01 Jan 2016 by FirstWord Pharma USD $2,195 More Info
Biosimilars: Regulatory Outlook
IntroductionBiosimilars offer a chance to improve access to, and reduce spending on, life-saving bio...
01 Nov 2015 by FirstWord Pharma USD $2,195 More Info
The Future of Biosimilars 2015
IntroductionThe Future of Biosimilars 2015 offers expert insight and opinion on the key issues facin...
01 Jun 2015 by FirstWord Pharma USD $2,195 More Info
Biosimilars: US Payer Perspectives
IntroductionBiosimilars: US Payer Perspectives pulls back the curtain on the US biologics market and...
01 Apr 2015 by FirstWord Pharma USD $2,195 More Info
Biosimilars: European Payer Perspectives
IntroductionCost is king when it comes to European biosimilars. One issue unites European healthca...
06 Jan 2015 by FirstWord Pharma USD $2,195 More Info
The Future of Biosimilars: mapping critical uncertainties and the impact of future events
IntroductionThe Future of Biosimilars: Mapping Critical Uncertainties and the Impact of Future Event...
05 May 2014 by FirstWord Pharma USD $1,950 More Info
Commercialisation of Biosimilars: strategies for market penetration
IntroductionTimes, they are a-changin’—at least for the American biological product market. With fiv...
01 Nov 2013 by FirstWord Pharma USD $695 More Info
Biosimilars in Emerging Markets
IntroductionWhat are the implications for regulators, biosimilar companies and branded manufacturers...
01 Mar 2013 by FirstWord Pharma USD $665 More Info

This report is published by AnalystView

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.

These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.

We aim to be the number one choice for various clients who require credible data to make vital business decisions. We wish to be a trusted and reliable analytics partner to major business organizations.

We understand that critical business decisions can be taken only when verified, authentic information is available. Therefore, our experts work meticulously to provide our clients with the accurate data, so that they need not spend time in verifying it.

It is also our goal to help our clients ignore traditional research methods that require a large amount of capital, manpower, and most important of it all – the time. We know that these factors are precious to a company and always follow the latest research techniques that produce the required result in a short span of time.

Download Free Report Summary PDF

Biosimilars Market, By Product Type (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Recombinant Peptides), Application (Oncology, Blood Disorders, Infectious Diseases, Autoimmune Diseases, Other Diseases) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...